Evidence map›Paper›PMID 40159669›Full record

ReviewMedical science monitor : international medical journal of experimental and clinical research2025

Review of Paraneoplastic Syndromes in Children with Malignancy.

Małgorzata Mitur-Lesiuk, Maciej Dubaj, Mateusz Raniewicz, Karol Bigosiński, Aleksandra Dembowska-Kupień

Abstract readReview
In one paragraph

Review in Medical science monitor : international medical journal of experimental and clinical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Ten tips for kidney biopsy in cancer patients.Clinical kidney journal · 2026
    Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Małgorzata Mitur-LesiukDepartment of Paediatric Haematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland.ORCID 0000-0003-1732-0441
Maciej DubajStudent Scientific Society of the Department of Paediatric Haematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland.ORCID 0000-0003-4709-8677
Mateusz RaniewiczStudent Scientific Society of the Department of Paediatric Haematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland.ORCID 0009-0000-0359-1086
Karol BigosińskiStudent Scientific Society of the Department of Paediatric Haematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland.ORCID 0000-0003-3613-3772
Aleksandra Dembowska-KupieńStudent Scientific Society of the Department of Paediatric Haematology, Oncology and Transplantology, Medical University of Lublin, Lublin, Poland.ORCID 0000-0002-2011-7420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A paraneoplastic syndrome (PNS) is a set of symptoms and signs that can accompany the formation of a cancer but is not due to its direct infiltration or metastasis. PNS results from the secretion of peptides or hormones by tumor cells or from an immunological cross-reaction between the tumor antigens and host antigens. In the adult population, PNS affects up to 15% of patients with cancer, but data on pediatric patients remain lacking. The remarkable fact is that PNS can precede an oncology diagnosis, even by months or years. PNS can involve virtually any organ of the human body. In children, the most commonly involved are the nervous system (encephalitis, opsoclonus-myoclonus syndrome), skin (pemphigus, alopecia areata, pruritic skin, pyoderma gangrenosum, skin nevi), rheumatologic (dermatomyositis, vasculitis), liver (atrophic biliary syndrome, idiopathic cholestasis), endocrine system (hypercalcemia, syndrome of inadequate secretion of antidiuretic hormone), kidney (nephrotic syndrome), or hematopoietic system (hemolytic anemia, thrombocytopenia, eosinophilia, thrombotic macroangiopathy, leukomoid reaction). PNS can accompany all childhood cancers, but is most common in Hodgkin lymphoma, acute lymphoblastic and myeloid leukemia, neuroblastoma, Wilms tumor, and sarcoma. Diagnosis of PNS should begin as early as the suspicion of its unusual course, lack of response to standard treatment, or prolonged duration. Diagnosis should include typical disease-specific tests and simultaneous imaging of the head and neck, abdomen, and pelvis, as well as a bone marrow biopsy to look for malignancy. PNS treatment mainly includes anti-tumor therapy and sometimes additional immunosuppressive therapy. This article aims to review PNS in children with malignancy.

Indexed as

NeoplasmsParaneoplastic SyndromesChildHumans

Identifiers

PMID40159669
PMCPMC11970335

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.